NeuroOne Medical Shares Are Trading Higher After the Company Reported a Year-over-year Increase in FY24 Annual Results and Issued Expectations for a Year-over-year Increase in Its FY25 Product Revenue Guidance.

BenzingaDec 18 03:45

Earnings Call Summary | NeuroOne Medical(NMTC.US) Q4 2024 Earnings Conference

Futu NewsDec 17 22:53 · Conference Call

NeuroOne Medical Technologies GAAP EPS of -$0.46, Revenue of $3.45M

Seeking AlphaDec 17 22:05

NeuroOne Medical | 10-K: FY2024 Annual Report

SECDec 17 21:33 · Announcements

NeuroOne Medical Tech 4Q Rev $3.5M >NMTC

Dow JonesDec 17 21:32

Express News | Neuroone® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

BreakingsDec 17 21:30